By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Scientific Parc EPFL, PSE-C

Lausanne    CH-1015  Switzerland
Phone: 41-21-6939051 Fax: 41-21-5604291



Company News
Genomic Health (GHDX) And Biocartis Announce Agreement To Develop An Idylla IVD Oncotype DX Breast Cancer Test To Broaden Global Patient Access 9/13/2017 6:22:31 AM
Biocartis' Idylla Instrument And Idylla Console Exempt From U.S. FDA 510(K) Notification Requirements 7/12/2017 11:07:55 AM
Biocartis And A*STAR’s ETPL Initiate Development Of Breast Cancer Assay To Guide Therapy Selection 7/10/2017 11:45:10 AM
Biocartis Announces Launch Of Influenza-Respiratory Virus Panel On The Idylla Platform 12/1/2015 10:31:33 AM
Biocartis Q3 2015 Business Update 11/20/2015 12:58:32 PM
Biocartis Announces H1 2015 Results And Strengthening Of Management Team 9/14/2015 9:17:07 AM
Biocartis Release: Notice Of Results For The Six Months Ended 30 June 2015 9/3/2015 2:25:04 PM
Biocartis And Fast-Track Diagnostics Sign Strategic Collaboration In Infectious Diseases 5/27/2015 1:09:22 PM
Biocartis Announces Exercise Of The Over-Allotment Option In Full Bringing The Gross Proceeds Of Its Initial Public Offering To Eur115 Million 5/19/2015 3:39:08 PM
Biocartis Raises EUR 100 Million In Successful IPO 4/24/2015 11:02:09 AM